Trials / Completed
CompletedNCT00214032
Pycnogenol for the Treatment of Lymphedema
Treatment of Arm Lymphedema in Breast Cancer Survivors: A Double-Blind, Randomized Study of Pycnogenol vs. Placebo
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- University of Wisconsin, Madison · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to evaluate the effectiveness of Pycnogenol (French maritime pine bark extract) for arm lymphedema in women following treatment for breast cancer, to evaluate the accuracy and sensitivity of bioelectric impedence as a measurement of lymphedema of the arm, and to validate the proposed arm lymphedema quality-of-life questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pycnogenol | pycnogenol 300 mg daily |
| DRUG | Placebo | placebo 3 capsules daily |
Timeline
- Start date
- 2002-05-01
- Primary completion
- 2006-11-01
- Completion
- 2007-01-01
- First posted
- 2005-09-21
- Last updated
- 2015-10-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00214032. Inclusion in this directory is not an endorsement.